Search for: "DuPont Nutrition Biosciences ApS" Results 1 - 11 of 11
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jul 2013, 11:00 pm by Courtenay Brinckerhoff
DuPont Nutrition Biosciences APS, the Federal Circuit determined that the Novozymes amylase patent at issue did not satisfy the written description requirement of 35 USC § 112, because the disclosure did not demonstrate possession of the claimed subject matter as a whole. [read post]
4 Oct 2013, 11:14 am
DuPont Nutrition Biosciences APS, 723 F.3d 1336 (Fed. [read post]
23 Jul 2013, 8:43 am by Lawrence B. Ebert
(collectively, “Novozymes”) andDefendants - Appellees DuPont Nutrition Biosciences APS,Genencor International Wisconsin, Inc., Danisco US Inc. [read post]
13 Jun 2017, 2:55 pm by Lawrence B. Ebert
DuPont Nutrition Biosciences APS, 723F.3d 1336, 1349 (Fed. [read post]
16 Jul 2021, 12:53 pm by Lawrence B. Ebert
DuPont Nutrition Biosciences APS, 723 F.3d 1336, 1349 (Fed. [read post]
14 Feb 2019, 3:03 pm by Lawrence B. Ebert
DuPont Nutrition Biosciences APS, 723F.3d 1336, 1350 (Fed. [read post]
29 Jul 2013, 2:37 pm by Gene Quinn
Novozymes sued DuPont Nutrition Biosciences APS, Genencor International Wisconsin, Inc., Danisco US Inc., and Danisco USA Inc. [read post]
16 Mar 2020, 9:12 am by Lawrence B. Ebert
DuPont Nutrition Biosciences APS, 723F.3d 1336, 1350 (Fed. [read post]
16 Oct 2013, 4:52 am by Jim Singer
DuPont Nutrition Biosciences  APS, the Federal Circuit found a patent to be invalid because its application (including a corresponding provisional) failed to show that the applicants actually understood the invention at the time of filing. [read post]
4 Sep 2013, 3:32 am by Lawrence B. Ebert
DuPont Nutrition Biosciences APS, No. 2012-1433, 2013 WL 3779376, at *14 (Fed. [read post]